nach oben

Erschienen in:

01.12.2010 | Original Article

Association of Depression with Antihypertensive Medication Adherence in Older Adults: Cross-Sectional and Longitudinal Findings from CoSMO

verfasst von: Marie Krousel-Wood, M.D., M.S.P.H., Tareq Islam, M.P.H., Paul Muntner, Ph.D., Elizabeth Holt, Ph.D., M.P.H., Cara Joyce, M.S., Donald E. Morisky, Sc.D., M.S.P.H., Larry S. Webber, Ph.D., Edward D. Frohlich, M.D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Little is known about the associations between depressive symptoms, social support and antihypertensive medication adherence in older adults.

Purpose

We evaluated the cross-sectional and longitudinal associations between depressive symptoms, social support and antihypertensive medication adherence in a large cohort of older adults.

Methods

A cohort of 2,180 older adults with hypertension was administered questionnaires, which included the Center for Epidemiologic Studies-Depression Scale, the Medical Outcomes Study Social Support Index, and the hypertension-specific Morisky Medication Adherence Scale at baseline and 1 year later.

Results

Overall, 14.1% of participants had low medication adherence, 13.0% had depressive symptoms, and 33.9% had low social support. After multivariable adjustment, the odds ratios that participants with depressive symptoms and low social support would have low medication adherence were 1.96 (95% confidence interval (CI) 1.43, 2.70) and 1.27 (95% CI 0.98, 1.65), respectively, at baseline and 1.87 (95% CI 1.32, 2.66) and 1.30 (95% CI 0.98, 1.72), respectively, at 1 year follow-up.

Conclusion

Depressive symptoms may be an important modifiable barrier to antihypertensive medication adherence in older adults

Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289:2560-2572.CrossRefPubMed

Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:69-75.CrossRefPubMed

Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199-206.CrossRefPubMed

Burnier M, Santschi V, Favrat B, et al. Monitoring compliance in resistant hypertension: Important step in patient management. J Hypertens. 2003;21:S37-S42.CrossRef

Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.CrossRefPubMed

DiMatteo MR. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care. 2004;42:200-209.CrossRefPubMed

DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: A meta-analysis. Med Care. 2002;40:794-811.CrossRefPubMed

Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26:483-492.CrossRefPubMed

Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504-511.CrossRefPubMed

10.

Maguire LK, Hughes CM, McElnay JC. Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension—a primary care study. Patient Educ Couns. 2008;73:371-376.CrossRefPubMed

11.

Wang PS, Avorn J, Brookhart MA, et al. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension. 2005;46:273-279.CrossRefPubMed

12.

Morisky DE, Ang A, Krousel-Wood MA, Ward H. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348-354.CrossRef

13.

DiMatteo MR. Social support and patient adherence to medical treatment: A meta-analysis. Health Psychol. 2004;23:207-218.CrossRefPubMed

14.

Lett HS, Blumenthal JA, Babyak MA, Strauman TJ, Robins C, Sherwood A. Social support and coronary heart disease: Epidemiologic evidence and implications for treatment. Psychosom Med. 2005;67:869-878.CrossRefPubMed

15.

Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS. Barriers to and determinants of medication adherence in hypertension management: Perspective of the cohort study of medication adherence among older adults (CoSMO). Med Clin N Am. 2009;93:753-769.CrossRefPubMed

16.

Krousel-Wood MA, Muntner P, Jannu A, Hyre A, Breault J. Does waiver of written informed consent from the Institutional Review Board affect response rate in a low risk research study? J Invest Med. 2006;54:174-179.CrossRef

17.

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidiity in longitudinal studies: Development and validation. J Chron Dis. 1987;40:373-383.CrossRefPubMed

18.

Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM Administrative Databases. J Clin Epidemiol. 1992;45:613-619.CrossRefPubMed

19.

Krousel-Wood MA, Islam T, Webber LS, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in hypertensive seniors. Am J Manag Care. 2009;15:59-66.PubMed

20.

Kopjar B, Sales AEB, Pineros SL, Sun H, Yu-Fang L, Hedeen AN. Adherence with statin therapy in secondary prevention of coronary heart disease in Veterans Administration male population. Am J Cardiol. 2003;92:1106-1108.CrossRefPubMed

21.

Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: Implications for health care costs. Clin Ther. 1997;19:1446-1457.CrossRefPubMed

22.

Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11:449-457.PubMed

23.

Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence. Am Heart J. 2003;145:438-444.CrossRefPubMed

24.

Knight RG, Williams S, McGee R, Olaman S. Psychometric properties of the Center for Epidemiologic Studies Depression Scale (CES-D) in a sample of women in middle life. Behav Res Therapy. 1997;35:373-380.CrossRef

25.

Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.CrossRef

26.

Roberts RE, Vernon SW, Rhoades HM. Effects of language and ethnic status on reliability and validity of the CES-D with psychiatric patients. J Nerv Ment Dis. 1989;177:581-592.CrossRefPubMed

27.

Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;705-714.

28.

Stewart AL, Hays RD, Ware JE. Short-Form General Health Survey. Reliability and validity in a patient population. Med Care. 1988;26:724-735.CrossRefPubMed

29.

Krousel-Wood M, Thomas S, Muntner P, et al. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19:357-362.CrossRefPubMed

30.

Bogner HR, Cary MS, Bruce ML, et al. The role of medical comorbidity in outcome of major depression in primary care: The PROSPECT study. Am J Geriatr Psychiatry. 2005;13:861-868.PubMed

31.

Bogner HR, Morales KH, Post EP, Bruce ML. Diabetes, depression, and death: A randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care. 2007;30:3005-3010.CrossRefPubMed

32.

Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278-3285.CrossRefPubMed

33.

Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160:1818-1823.CrossRefPubMed

34.

Scalco AZ, Scalco MZ, Azul JB, Lotufo NF. Hypertension and depression. Clinics. 2005;60:241-250.CrossRefPubMed

35.

DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101-2107.CrossRefPubMed

36.

Kim MT, Han HR, Hill MN, Rose L, Roary M. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med. 2003;26:24-31.CrossRefPubMed

37.

Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav. 2009;36:127-137.CrossRefPubMed

38.

Bogner HR, de Vries HF. Integration of depression and hypertension treatment: A pilot, randomized controlled trial. Ann Fam Med. 2008;6:295-301.CrossRefPubMed

39.

Henkel V, Seemuller F, Obermeier M, et al. Does early improvement triggered by antidepressants predict response/remission?—Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord. 2008;115:439-449.CrossRefPubMed

40.

Delamater AM. Improving patient adherence. Clinical Diabetes. 2006;24:71-77.CrossRef

41.

Kahana S, Drotar D, Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol. 2008;33:590-611.CrossRefPubMed

42.

Lebowitz BD. Diagnosis and treatment of depression in late life. Am J Geriatr Psychiatry. 1996;4:S3-S6.

43.

Amsterdam JD, Garcia-Espana F, Fawcett J, et al. Blood pressure changes during short-term fluoxetine treatment. J Clin Psychopharmacol. 1999;19:9-14.CrossRefPubMed

44.

Scalco MZ, de Almeida OP, Hachul DT, Castel S, Serro-Azul J, Wajngarten M. Comparison of risk of orthostatic hypotension in elderly depressed hypertensive women treated with nortriptyline and thiazides versus elderly depressed normotensive women treated with nortriptyline. Am J Cardiol. 2000;85:1156-1158.CrossRefPubMed

45.

Hawkshead J, Krousel-Wood MA. Techniques of measuring medication adherence in hypertensive patients in outpatient settings: Advantages and limitations. Dis Manag Health Outcomes. 2007;15:109-118.CrossRef

Titel: Association of Depression with Antihypertensive Medication Adherence in Older Adults: Cross-Sectional and Longitudinal Findings from CoSMO
verfasst von: Marie Krousel-Wood, M.D., M.S.P.H.
Tareq Islam, M.P.H.
Paul Muntner, Ph.D.
Elizabeth Holt, Ph.D., M.P.H.
Cara Joyce, M.S.
Donald E. Morisky, Sc.D., M.S.P.H.
Larry S. Webber, Ph.D.
Edward D. Frohlich, M.D.
Publikationsdatum: 01.12.2010
Verlag: Springer-Verlag
Erschienen in: Annals of Behavioral Medicine / Ausgabe 3/2010
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI: https://doi.org/10.1007/s12160-010-9217-1

Neu in den Fachgebieten Neurologie und Psychiatrie

23.04.2024 | Demenz | Nachrichten

Springer Medizin

Association of Depression with Antihypertensive Medication Adherence in Older Adults: Cross-Sectional and Longitudinal Findings from CoSMO

Abstract

Background

Purpose

Methods

Results

Conclusion

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Springer Medizin

Abstract

Background

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Intentions to Quit Smoking: Causal Attribution, Perceived Illness Severity, and Event-Related Fear During an Acute Health Event

Genitourinary Functioning and Depressive Symptoms Over Time In Younger Versus Older Men Treated for Prostate Cancer

Waist Circumference Moderates the Association Between Marital Stress and C-reactive Protein in Middle-Aged Healthy Women

Television Viewing Time and Risk of Chronic Kidney Disease in Adults: The AusDiab Study

Dynamics of Changes in Self-Efficacy and Locus of Control Expectancies in the Behavioral and Drug Treatment of Severe Migraine

Family Functioning and Weight Loss in a Sample of African Americans and Whites

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein